Literature DB >> 31019961

Assessing the feasibility of a chatbot after ureteroscopy.

Steven B Goldenthal1,2, David Portney1,2, Emma Steppe1, Khurshid Ghani1, Chad Ellimoottil1.   

Abstract

BACKGROUND: Patients experience common symptoms and/or complications after undergoing ureteroscopy, which is a common procedure used to treat kidney stones. Current methods for patient education regarding these complications include counseling and discharge materials. This study aimed to assess chatbot usage and their ability to deliver information to patient post-ureteroscopy.
METHODS: Patients who underwent ureteroscopy at the University of Michigan were given instructions to activate the chatbot. Within one to four weeks of their surgery, semi-structured interviews were conducted regarding post-surgical recovery and chatbot usage.
RESULTS: Twenty patients were interviewed, seven of whom activated the chatbot. Frequent reasons for not activating the chatbot included misplacing instructions for chatbot use (n=6), relying on follow-up with clinic or discharge materials (n=4), inability to activate chatbot (n=2), and inability to text (n=1). Perceived benefits included alleviation of concerns surrounding common symptoms and quick access to information for non-emergent issues.
CONCLUSIONS: These results suggest that chatbots are a convenient method to address common concerns post-ureteroscopy. However, better integration in the flow of care delivery and improved usability are needed to increase patient engagement.

Entities:  

Keywords:  Chatbot; mobile health; smartphones; ureteroscopy

Year:  2019        PMID: 31019961      PMCID: PMC6458345          DOI: 10.21037/mhealth.2019.03.01

Source DB:  PubMed          Journal:  Mhealth        ISSN: 2306-9740


  7 in total

Review 1.  Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi.

Authors:  Omar M Aboumarzouk; Slawomir G Kata; Francis X Keeley; Samuel McClinton; Ghulam Nabi
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  A Randomized Controlled Trial of a Mobile Health Intervention to Promote Self-Management After Lung Transplantation.

Authors:  A DeVito Dabbs; M K Song; B A Myers; R Li; R P Hawkins; J M Pilewski; C A Bermudez; J Aubrecht; A Begey; M Connolly; M Alrawashdeh; M A Dew
Journal:  Am J Transplant       Date:  2016-03-14       Impact factor: 8.086

3.  The impact of unplanned postprocedure visits in the management of patients with urinary stones.

Authors:  Charles D Scales; Christopher S Saigal; Janet M Hanley; Andrew W Dick; Claude M Setodji; Mark S Litwin
Journal:  Surgery       Date:  2013-12-16       Impact factor: 3.982

4.  Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure.

Authors:  H B Joshi; N Newns; A Stainthorpe; R P MacDonagh; F X Keeley; A G Timoney
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

5.  Postoperative monitoring with a mobile application after ambulatory lumbar discectomy: an effective tool for spine surgeons.

Authors:  Bertrand Debono; Philippe Bousquet; Pascal Sabatier; Jean-Yves Plas; Jean-Paul Lescure; Olivier Hamel
Journal:  Eur Spine J       Date:  2016-06-27       Impact factor: 3.134

6.  Post-discharge follow-up using text messaging within an enhanced recovery program after colorectal surgery.

Authors:  G Carrier; E Cotte; L Beyer-Berjot; J L Faucheron; J Joris; K Slim
Journal:  J Visc Surg       Date:  2016-08-08       Impact factor: 2.043

Review 7.  Application of Synchronous Text-Based Dialogue Systems in Mental Health Interventions: Systematic Review.

Authors:  Simon Hoermann; Kathryn L McCabe; David N Milne; Rafael A Calvo
Journal:  J Med Internet Res       Date:  2017-07-21       Impact factor: 5.428

  7 in total
  1 in total

1.  Automated conversational agents for post-intervention follow-up: a systematic review.

Authors:  L Geoghegan; A Scarborough; J C R Wormald; C J Harrison; D Collins; M Gardiner; J Bruce; J N Rodrigues
Journal:  BJS Open       Date:  2021-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.